MCM
AMGN icon

Matarin Capital Management’s Amgen AMGN Stock Holding History

Matarin Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-25,878
Closed -$4.77M – 249
2019
Q2 		$4.77M Buy
25,878
+2,366
+10% +$424K 0.34% 110
2019
Q1 		$4.47M Sell
23,512
-21
-0.1% -$4.01K 0.32% 110
2018
Q4 		$4.58M Buy
23,533
+1,868
+9% +$364K 0.37% 99
2018
Q3 		$4.49M Buy
21,665
+6,325
+41% +$1.25M 0.29% 113
2018
Q2 		$2.83M Buy
15,340
+7,975
+108% +$1.41M 0.2% 151
2018
Q1 		$1.26M Buy
7,365
+18
+0.2% +$3.3K 0.09% 198
2017
Q4 		$1.28M Buy
7,347
+534
+8% +$94.5K 0.1% 195
2017
Q3 		$1.27M Buy
+6,813
New +$1.21M 0.11% 184

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Matarin Capital Management's AMGN Position: Q3 2019 in Review

Matarin Capital Management sold out of Amgen (AMGN) in Q3 2019, closing a stake of 25,878 shares — an estimated $4.77M sold.

Matarin Capital Management first reported a position in AMGN in Q3 2017 and held it in 8 quarters. The position peaked at $4.77M in Q2 2019. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Matarin Capital Management reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
  • Matarin Capital Management sold 25,878 Amgen shares in Q3 2019, an estimated $4.77M.
  • Matarin Capital Management first reported a position in Amgen in Q3 2017 and held it in 8 quarters.
  • Matarin Capital Management's Amgen position peaked at $4.77M in Q2 2019.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Matarin Capital Management's 13F filing for Q3 2019, filed 5 Nov 2019.